Earlier DLBCL classification studies, for instance, mostly utilized decision tree algorithm and evaluated two to five antibodies, such as CD10, Bcl‐6, FOXP1, GCET1, and MUM‐1.6, 7, 8, 9, 16. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.